Balyasny Asset Management
AKCA

Balyasny Asset Management’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History

Balyasny Asset Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,647
Closed -$303K – 1692
2018
Q3 		$303K Buy
+8,647
New +$303K ﹤0.01% 1281